In recent trading session, Zomedica Corp (AMEX:ZOM) saw 0.53 million shares changing hands at last check today with its beta currently measuring 1.00. Company’s recent per share price level of $0.13 trading at $0.0 or 0.68% at last check today assigns it a market valuation of $131.02M. That most recent trading price of ZOM’s stock is at a discount of -92.31% from its 52-week high price of $0.25 and is indicating a premium of 7.69% from its 52-week low price of $0.12. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 4.23 million shares which gives us an average trading volume of 5.71 million if we extend that period to 3-months.
Zomedica Corp (AMEX:ZOM) trade information
Upright in the green today for gaining 0.68%, in the last five days ZOM remained trading in the red while hitting it’s week-highest on Wednesday, 03/20/24 when the stock touched $0.13 price level, adding 3.7% to its value on the day. Zomedica Corp’s shares saw a change of -33.22% in year-to-date performance and have moved -0.52% in past 5-day. Zomedica Corp (AMEX:ZOM) showed a performance of 4.37% in past 30-days. Number of shares sold short was 64.63 million shares which calculate 11.91 days to cover the short interests.
Zomedica Corp (ZOM) estimates and forecasts
Statistics highlight that Zomedica Corp is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -21.45% of value to its shares in past 6 months, showing an annual growth rate of 0.00% while that of industry is 3.30. This year revenue growth is estimated to rise 31.30% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $7 million for the same. And 1 analysts are in estimates of company making revenue of $8.18 million in the next quarter that will end on Mar 2024. Company posted $6.16 million and $5.48 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 13.70% while estimating it to be 49.20% for the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 28.01% during past 5 years.
ZOM Dividends
Zomedica Corp is more likely to be releasing its next quarterly report on April 01 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Zomedica Corp (AMEX:ZOM)’s Major holders
Insiders are in possession of 1.64% of company’s total shares while institution are holding 9.17 percent of that, with stock having share float percentage of 9.32%. Investors also watch the number of corporate investors in a company very closely, which is 9.17% institutions for Zomedica Corp that are currently holding shares of the company. Vanguard Group Inc is the top institutional holder at ZOM for having 48.9 million shares of worth $6.54 million. And as of Dec 30, 2023, it was holding 4.99% of the company’s outstanding shares.
The second largest institutional holder is Blackrock Inc., which was holding about 10.39 million shares on Dec 30, 2023. The number of shares represents firm’s hold over 1.06% of outstanding shares, having a total worth of $1.39 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 30, 2023, the former fund manager was holding 33.69 million shares of worth $4.5 million or 3.44% of the total outstanding shares. The later fund manager was in possession of 13.41 million shares on Dec 30, 2023, making its stake of worth around $1.79 million in the company or a holder of 1.37% of company’s stock.
